We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNGR:NASDAQFingerMotion, Inc. Analysis

Data as of 2026-05-29 - not real-time

$0.77

Latest Price

8/10Risk

Risk Level: High

Executive Summary

FingerMotion, Inc. is trading at $0.77, barely above its calculated support of $0.75, with the 20‑day SMA (0.86) and 50‑day SMA (0.95) sitting well above the current price, indicating a continued bearish bias. Technical indicators reinforce this view: RSI is near 41 (neutral), MACD shows a bearish crossover, volume is trending lower, and 30‑day volatility exceeds 110% while beta is 1.89, all pointing to heightened price instability and a recent max drawdown of roughly 75%.
Fundamentally, the company is under severe pressure: revenue fell 32% YoY, gross margin is a meager 5%, operating and profit margins are deep in the red, and cash flow is negative. Debt levels (≈$423k) dwarf the cash on hand (<$25k), resulting in a debt‑to‑equity ratio above 2.5. Yet the discounted cash flow model suggests a fair value of only $0.036, implying the market may be overpaying relative to intrinsic estimates, while the forward PE of 25.7 exceeds the industry average of 17, hinting at valuation concerns. Recent material news – the national certification of the C2 platform by China’s MIIT and a strategic alliance for emergency‑response vehicles – could serve as catalysts for future revenue diversification, but the upside remains speculative given the current financial distress.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price near support with bearish SMA alignment
  • Negative technical momentum (MACD, RSI)
  • Decreasing volume and extreme volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from C2 platform certification
  • Strategic alliance for emergency‑response vehicles
  • Continued financial losses and high debt load

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • DCF fair value suggests deep discount to market price
  • Long‑term growth opportunity in 5G and big‑data services
  • High risk profile requires strong conviction in turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth-32.10%
Profit Margin-16.07%
P/E Ratio25.7
ROE-41.31%
ROA-8.37%
Debt/Equity2.59
P/B Ratio2.9
Op. Cash Flow$-7227133
Free Cash Flow$198.1K
Industry P/E17.0

Technical Analysis

TrendBearish
RSI40.7
Support$0.75
Resistance$1.10
MA 20$0.86
MA 50$0.95
MA 200$1.30
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07

Valuation

Fair Value$0.04
GradeUndervalued
TypeValue

Risk Assessment

Beta1.89
Volatility111.25%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.